Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response

Agriculture & Biology

• viral load 100%
• Macaca mulatta 87%
• T-lymphocytes 78%
• immune response 71%
• therapeutics 67%
• major histocompatibility complex 59%
• virus replication 57%
• alleles 47%
• infection 45%
• antiretroviral agents 30%
• acquired immunodeficiency syndrome 27%
• Human immunodeficiency virus 24%
• antiviral agents 24%
• disease progression 22%
• vaccine development 21%
• Human immunodeficiency virus 1 21%
• cell-mediated immunity 18%
• clinical trials 18%
• Primates 15%
• animals 14%
• duration 10%

Medicine & Life Sciences

• Macaca mulatta 90%
• Viral Load 83%
• T-Lymphocytes 53%
• Major Histocompatibility Complex 52%
• Alleles 50%
• Mamu-A 01 antigen 41%
• Infections 41%
• Animals 17%
• Cellular Immunity 16%
• Primates 16%
• HIV-1 15%
• Antiviral Agents 14%
• Acquired Immunodeficiency Syndrome 14%
• Therapeutics 14%
• Disease Progression 13%
• Vaccines 12%
• Virus Diseases 12%
• Clinical Studies 11%
• HIV 11%
• Pharmaceutical Preparations 7%